Ligand Pharmaceuticals' GAAP net income for 9M 2021 was $62.554 million, compared to a loss of $8.746 million in the previous year. Revenue increased 75.8% to $204.66 million from $116.429 million a year earlier.
Ligand Pharmaceuticals' GAAP net income for 9M 2021 was $62.554 million, compared to a loss of $8.746 million in the previous year. Revenue increased 75.8% to $204.66 million from $116.429 million a year earlier. 
investor.ligand.com
English (US) 